NLS Pharmaceutics AG (NLSP) - Quarterly Balance Statement

Home
NLSP
Financials

0.1368 (USD) • At close September 18, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2023 Q4	2023 Q2	2022 Q4	2022 Q2	2021 Q4	2021 Q2	2020 Q4	2020 Q2	2019 Q4	2019 Q2	2018 Q4
Assets:
Current Assets:
Cash & Cash Equivalents Numbers are in millions	0.898	1.651	8.948	1.354	5.431	7.092	0.094	0.145	0.22	1.225	0.007
Short Term Investments Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0
Cash and Short Term Investments Numbers are in millions	0.898	1.651	8.948	1.354	5.431	7.092	0.094	0.145	0.22	1.225	0.007
Net Receivables Numbers are in millions	0.011	0.064	0.041	0.06	0.039	0.043	0.061	0.013	0.075	0.01	0
Inventory Numbers are in millions	0	-0.064	-0.041	-0.06	-0.039	-0.043	-0.061	0	0	0	0
Other Current Assets Numbers are in millions	0.915	0.594	0.298	0.668	0.292	1.149	0.103	0.063	0.086	0.084	0.083
Total Current Assets Numbers are in millions	1.823	2.245	9.246	2.023	5.723	8.241	0.197	0.221	0.382	1.318	0.09
Non-Current Assets:
Property, Plant & Equipment, Net Numbers are in millions	0.007	0.012	0.018	0.024	0.03	0.028	0	0	0	0	0
Goodwill Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0
Intangible Assets Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0
Goodwill and Intangible Assets Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0
Long Term Investments Numbers are in millions	0	0	0	0	0	0	0.068	0.056	0.054	0.055	0
Tax Assets Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0
Other Non-Current Assets Numbers are in millions	0.017	0.013	0.012	0.012	0.012	-0	0.947	0.363	0.26	0	0.055
Total Non-Current Assets Numbers are in millions	0.024	0.025	0.03	0.036	0.042	0.028	1.015	0.419	0.315	0.055	0.055
Total Assets Numbers are in millions	1.847	2.27	9.277	2.058	5.765	8.269	1.212	0.64	0.696	1.374	0.146
Liabilities & Equity:
Current Liabilities:
Account Payables Numbers are in millions	4.634	3.113	2.373	2.522	1.737	0.527	4.006	2.756	2.509	1.854	1.131
Short Term Debt Numbers are in millions	1.634	0	0	0.354	-2,499.969	0	1.771	0.793	0.69	0.684	0.708
Tax Payables Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0
Deferred Revenue Numbers are in millions	0	0	0	0	2,499.969	0	2,499.969	0	-0	0	0
Other Current Liabilities Numbers are in millions	1.652	0.779	0.986	0.535	0.666	0.666	-2,498.543	1.172	0.836	0.382	0.576
Total Current Liabilities Numbers are in millions	7.92	3.892	3.36	3.411	2.403	1.193	7.204	4.721	4.035	2.92	2.415
Non-Current Liabilities:
Long Term Debt Numbers are in millions	0	0	0	0	0	0	0.313	0.575	0.152	0	6.386
Deferred Revenue Non-Current Numbers are in millions	2.5	2.5	2.5	2.5	2.5	2.5	2.5	2.5	2.5	2.5	0
Deferred Tax Liabilities Non-Current Numbers are in millions	0	0	0	0	0	0	0	-0	0	0	0
Other Non-Current Liabilities Numbers are in millions	0.261	0.165	0.136	0.189	0.319	0.327	0.178	0.178	0.18	0.151	0.159
Total Non-Current Liabilities Numbers are in millions	2.761	2.665	2.636	2.689	2.819	2.827	2.992	3.253	2.832	2.651	6.545
Total Liabilities Numbers are in millions	10.68	6.557	5.996	6.1	5.222	4.02	10.196	7.974	6.867	5.571	8.959
Equity:
Preferred Stock Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0
Common Stock Numbers are in millions	0.733	0.733	0.669	0.411	0.344	0.26	0.145	0.145	0.145	0.145	0.134
Retained Earnings Numbers are in millions	-70.373	-65.814	-58.201	-50.347	-41.706	-34.363	-29.76	-28.13	-26.898	-24.866	-21.451
Accumulated Other Comprehensive Income/Loss Numbers are in millions	-0.158	-0.066	-0.051	-0.033	-0.152	-0.18	-0.019	-0.019	-0.019	-0.011	-0.011
Other Total Stockholders Equity Numbers are in millions	60.965	60.86	60.865	45.927	42.055	38.532	20.65	20.67	20.601	20.535	12.515
Total Shareholders Equity Numbers are in millions	-8.834	-4.287	3.281	-4.041	0.542	4.249	-8.984	-7.334	-6.171	-4.197	-8.814
Total Equity Numbers are in millions	-8.834	-4.287	3.281	-4.041	0.542	4.249	-8.984	-7.334	-6.171	-4.197	-8.814
Total Liabilities & Shareholders Equity Numbers are in millions	1.847	2.27	9.277	2.058	5.765	8.269	1.212	0.64	0.696	1.374	0.146

NLS Pharmaceutics AG

NASDAQ:NLSP Add to watchlist

NASDAQ:NLSP